Related references
Note: Only part of the references are listed.Laboratory diagnosis ofClostridium difficileinfection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory
M. W. D. Wren et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2016)
Effects of treatment with antimicrobial agents on the human colonic microflora
Fatemeh Rafii
Therapeutics and Clinical Risk Management (2016)
Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial with Patients with Clostridium difficile Infection
T. Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C-difficile Infection
Thomas J. Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Nitazoxanide versus Vancomycin in Clostridium difficile Infection: A Randomized, Double-Blind Study
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2009)
High Frequency of Rifampin Resistance Identified in an Epidemic Clostridium difficile Clone from a Large Teaching Hospital
Scott R. Curry et al.
CLINICAL INFECTIOUS DISEASES (2009)
Antimotility Agents for the Treatment of Clostridium difficile Diarrhea and Colitis
Hoonmo L. Koo et al.
CLINICAL INFECTIOUS DISEASES (2009)
Skin and Environmental Contamination With Vancomycin-Resistant Enterococci in Patients Receiving Oral Metronidazole or Oral Vancomycin Treatment for Clostridium difficile-Associated Disease
Ajay K. Sethi et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Current and future treatment modalities for Clostridium difficile-associated disease
Jennifer Halsey
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2008)
Rifampin and rifaximin resistance in clinical isolates of Clostfdium diicile
Jennifer R. O'Connor et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses
Y. K. Shue et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters
Eti Kokkotou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease
Wafa N. Al-Nassir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Predictors of mortality after colectomy for fulminant Clostridium difficile colitis
John C. Byrn et al.
ARCHIVES OF SURGERY (2008)
Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain
Alex Carignan et al.
CLINICAL INFECTIOUS DISEASES (2008)
In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin
Rachael O'Connor et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model
Simon D. Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin
Melinda J. Mayer et al.
JOURNAL OF BACTERIOLOGY (2008)
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
K. W. Garey et al.
JOURNAL OF HOSPITAL INFECTION (2008)
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
Marc G. H. Besselink et al.
LANCET (2008)
Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review
Tim Planche et al.
LANCET INFECTIOUS DISEASES (2008)
Clostridium difficile:: an under-recognized cause of reactive arthritis?
Julius Birnbaum et al.
CLINICAL RHEUMATOLOGY (2008)
Rapid and reliable diagnostic algorithm for detection of Clostridium difficile
Lukas Fenner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Clostridium difficile-associated disease in a setting of endemicity:: Identification of novel risk factors
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2007)
Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027
Jacques Pepin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis
Richard M. Cadle et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents
Michelle M. Riggs et al.
CLINICAL INFECTIOUS DISEASES (2007)
A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
Fred A. Zar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity:: a potential mechanism to explain the association between proton pump inhibitors and C-difficile-associated diarrhea?
Robin L. P. Jump et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004
David W. Hecht et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics:: randomised double blind placebo controlled trial
Mary Hickson et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Clostridium difficile colitis that fails conventional metronidazole therapy:: response to nitazoxanide
Daniel M. Musher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain
Francois Lamontagne et al.
ANNALS OF SURGERY (2007)
Systematic review of the risk of enteric infection in patients taking acid suppression
Jennifer Leonard et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Narrative review: The new epidemic of clostridium difficile-associated enteric disease
John G. Bartlett
ANNALS OF INTERNAL MEDICINE (2006)
Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile -: Associated diarrhea
Danny Lagrotteria et al.
CLINICAL INFECTIOUS DISEASES (2006)
Frequent emergence of resistance in Clostridium difficile during treatment of C-difficile-associated diarrhea with Fusidic acid
T. Noren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Nitazoxanide for the treatment of Clostridium difficile colitis
Daniel M. Musher et al.
CLINICAL INFECTIOUS DISEASES (2006)
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile -: Associated diarrhea
Thomas J. Louie et al.
CLINICAL INFECTIOUS DISEASES (2006)
Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2006)
Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin
JR Ticehurst et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality
VG Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Invasive Saccharomyces infection:: A comprehensive review
A Enache-Angoulvant et al.
CLINICAL INFECTIOUS DISEASES (2005)
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection
J Freeman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
M Warny et al.
LANCET (2005)
Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomvcin-resistant enterococci and extended- spectrum-β-lactamase-producing Klebsiella pneumoniae in mice
NJ Pultz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
DM Musher et al.
CLINICAL INFECTIOUS DISEASES (2005)
Saccharomyces cerevisiae fungemia:: An emerging infectious disease
P Muñoz et al.
CLINICAL INFECTIOUS DISEASES (2005)
Nitazoxanide: A new thiazolide antiparasitic agent
LM Fox et al.
CLINICAL INFECTIOUS DISEASES (2005)
Clostridium difficile toxins:: Mechanism of action and role in disease
DE Voth et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole
T Peláez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A large outbreak of Clostridium Difficile -: Associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use
CA Muto et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Rifalazil treats and prevents relapse of Clostridium difficile-associated diarrhea in hamsters
PM Anton et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea
W Braunlin et al.
BIOPHYSICAL JOURNAL (2004)
A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea
M Wullt et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea
MH Wilcox et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Bacteriotherapy using fecal flora - Toying with human motions
TJ Borody et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis
S Cherifi et al.
ACTA CLINICA BELGICA (2004)
Evidence for biliary excretion of vancomycin into stool during intravenous therapy: Potential implications for rectal colonization with vancomycin-resistant enterococci
BP Currie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro activity of OPT-80 against clostridium difcile
G Ackermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Outcome after colectomy for Clostridium difficile colitis
WE Longo et al.
DISEASES OF THE COLON & RECTUM (2004)
Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube
J Aas et al.
CLINICAL INFECTIOUS DISEASES (2003)
Colonization for the prevention of Clostridium difficile disease in hamsters
SP Sambol et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Clostridium difficile in long-term-care facilities for the elderly
AE Simor et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2002)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin
T Peláez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Antibiotic-associated diarrhea
JG Bartlett
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Severe Clostridium difficile colitis: The role of intracolonic vancomycin?
A Apisarnthanarak et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin a immunoassay
S Johnson et al.
ANNALS OF INTERNAL MEDICINE (2001)
Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea
C Yip et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2001)
GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis
CB Kurtz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
L Kyne et al.
LANCET (2001)
Clostridium difficile toxin and faecal lactoferrin assays in adult patients
C Vaishnavi et al.
MICROBES AND INFECTION (2000)
The search for a better treatment for recurrent Clostridium difficile disease:: Use of high-dose vancomycin combined with Saccharomyces boulardii
CM Surawicz et al.
CLINICAL INFECTIOUS DISEASES (2000)
In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species
A Marchese et al.
CHEMOTHERAPY (2000)
Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
L Kyne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
In vitro and in vivo activities of nitazoxanide against Clostridium difficile
CS McVay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Gastric acid suppression does not promote clostridial diarrhoea in the elderly
S Shah et al.
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS (2000)
Share Paper
